Are COVID-19 vaccines safe in pregnancy?
Level 5 - mechanism / opinion, no new human data
Narrative review/commentary summarizing early trial observations without systematic methodology
PubMed 33658707 · doi:10.1038/s41577-021-00525-y
What was done
This commentary examined early evidence regarding COVID-19 vaccination, fertility, and pregnancy, focusing on accidental pregnancies that occurred during initial clinical trials from which pregnant individuals were explicitly excluded.
What was found
The abstract provides no numerical data, effect estimates, or sample sizes. It reports qualitatively that data from incidental pregnancies during clinical trials of approved COVID-19 vaccines indicate that vaccination does not harm fertility or increase the rate of miscarriage.
Why it matters
It provided early contextual reassurance regarding fertility and miscarriage risk at the beginning of the worldwide COVID-19 vaccine rollout when dedicated pregnancy trial data were unavailable.
Limits
The abstract lacks quantitative metrics, statistical comparisons, and sample sizes. The findings rely on small numbers of incidental pregnancies from trials that excluded pregnant participants rather than dedicated, prospective clinical safety trials in pregnant populations.
Cited by
- supports In the phase 3 trials for Pfizer, Moderna, AstraZeneca, and Johnson & Johnson COVID-19 vaccines, there were no statistically significant differences in pregnancy rates or miscarriages between the vaccinated and control groups.